Eric Padron

Eric Padron

UNVERIFIED PROFILE

Are you Eric Padron?   Register this Author

Register author
Eric Padron

Eric Padron

Publications by authors named "Eric Padron"

Are you Eric Padron?   Register this Author

100Publications

2864Reads

47Profile Views

Driver mutation-specific clinical and genomic correlates differ between primary and secondary myelofibrosis.

Am J Hematol 2019 Aug 23. Epub 2019 Aug 23.

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25625DOI Listing
August 2019

A phase 2 trial of the oral smoothened inhibitor glasdegib in refractory myelodysplastic syndromes (MDS).

Leuk Res 2019 Jun 30;81:56-61. Epub 2019 Mar 30.

Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2019.03.008DOI Listing
June 2019

Relapsed Acute Lymphoblastic Leukemia Presenting as Acute Renal Failure.

Case Rep Nephrol 2019 13;2019:7913027. Epub 2019 May 13.

Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33602, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2019/7913027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535833PMC
May 2019

Leveraging Single-Cell RNA Sequencing Experiments to Model Intratumor Heterogeneity.

JCO Clin Cancer Inform 2019 04;3:1-10

Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/CCI.18.00074DOI Listing
April 2019

Detection of Novel t(12;17)(p12;p13) in Relapsed Refractory Acute Myeloid Leukemia by Anchored Multiplex PCR(AMP)-based Next-Generation Sequencing.

Appl Immunohistochem Mol Morphol 2019 Mar;27(3):e28-e31

Department of Hematopathology and Laboratory Medicine, Moffitt Cancer Center, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0000000000000477DOI Listing
March 2019

TP53 and therapy-related myeloid neoplasms.

Best Pract Res Clin Haematol 2019 03 19;32(1):98-103. Epub 2019 Feb 19.

Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2019.02.009DOI Listing
March 2019

Association of EZH2 protein expression by immunohistochemistry in myelodysplasia related neoplasms with mutation status, cytogenetics and clinical outcomes.

Br J Haematol 2019 Feb 23;184(3):450-455. Epub 2018 Jan 23.

Departments of Hematopathology and Clinical Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15099DOI Listing
February 2019

Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemia.

Sci Rep 2019 Jan 24;9(1):606. Epub 2019 Jan 24.

Department of Drug Discovery, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, 33612, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-018-37174-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345777PMC
January 2019

OMIP-049: Analysis of Human Myelopoiesis and Myeloid Neoplasms.

Cytometry A 2018 10;93(10):982-986

Departments of Immunology, H. Lee Moffitt Cancer Center, Tampa, Florida.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cyto.a.23598
Publisher Site
http://dx.doi.org/10.1002/cyto.a.23598DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484443PMC
October 2018

Current Management and Recent Advances in the Treatment of Chronic Myelomonocytic Leukemia.

Curr Treat Options Oncol 2018 10 27;19(12):67. Epub 2018 Oct 27.

Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, SRB 2nd Floor, 12902 USF Magnolia Drive, Tampa, FL, 33612, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11864-018-0581-6
Publisher Site
http://dx.doi.org/10.1007/s11864-018-0581-6DOI Listing
October 2018

Between a rux and a hard place: evaluating salvage treatment and outcomes in myelofibrosis after ruxolitinib discontinuation.

Ann Hematol 2018 Mar 30;97(3):435-441. Epub 2017 Nov 30.

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL, 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-017-3194-4DOI Listing
March 2018

The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes.

Ann Hematol 2018 Feb 22;97(2):247-254. Epub 2017 Nov 22.

Department of Malignant Hematology, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00277-017-3186-4
Publisher Site
http://dx.doi.org/10.1007/s00277-017-3186-4DOI Listing
February 2018

The Treatment Landscape of Myelofibrosis Before and After Ruxolitinib Approval.

Clin Lymphoma Myeloma Leuk 2017 Dec 5;17(12):e45-e53. Epub 2017 Aug 5.

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.08.002DOI Listing
December 2017

A Phase II Study of CLAG Regimen Combined With Imatinib Mesylate for Relapsed or Refractory Acute Myeloid Leukemia.

Clin Lymphoma Myeloma Leuk 2017 Dec 19;17(12):902-907. Epub 2017 Sep 19.

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.09.007DOI Listing
December 2017

ASXL1 frameshift mutations drive inferior outcomes in CMML without negative impact in MDS.

Blood Cancer J 2017 11 27;7(12):633. Epub 2017 Nov 27.

Hematopathology and Laboratory Medicine Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 36612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-017-0004-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802523PMC
November 2017

Chipping in on clonal hematopoiesis.

Oncotarget 2017 Oct 4;8(49):84637-84638. Epub 2017 Oct 4.

Eric Padron: Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.21472DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689560PMC
October 2017

Myelodysplasia in younger adults: outlier or unique molecular entity?

Haematologica 2017 06;102(6):967-968

Malignant Hematology Department, H. Lee Moffitt Cancer Center, Tampa, FL, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2017.165993DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451326PMC
June 2017

Evidence for Selective Benefit of Sequential Treatment With Hypomethylating Agents in Patients With Myelodysplastic Syndrome.

Clin Lymphoma Myeloma Leuk 2017 04 10;17(4):211-214. Epub 2017 Jan 10.

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2016.10.003DOI Listing
April 2017

Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.

Oncologist 2017 02 8;22(2):144-151. Epub 2017 Feb 8.

DeBartolo Family Personalized Medicine Institute, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2016-0195DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330702PMC
February 2017

Integrating Genomics in Myelodysplastic Syndrome to Predict Outcomes After Allogeneic Hematopoietic Cell Transplantation.

Clin Lymphoma Myeloma Leuk 2017 01 16;17(1):7-13. Epub 2016 Sep 16.

Department of Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL; Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, FL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2016.09.005DOI Listing
January 2017

An Exercise in Extrapolation: Clinical Management of Atypical CML, MDS/MPN-Unclassifiable, and MDS/MPN-RS-T.

Curr Hematol Malig Rep 2016 12;11(6):425-433

H. Lee Moffitt Cancer Center and Research Institute, Malignant Hematology, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-016-0350-1DOI Listing
December 2016

When clinical heterogeneity exceeds genetic heterogeneity: thinking outside the genomic box in chronic myelomonocytic leukemia.

Blood 2016 11 5;128(20):2381-2387. Epub 2016 Oct 5.

Malignant Hematology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-07-692988DOI Listing
November 2016

Surveying the landscape of MDS/MPN research: overlap among the overlap syndromes?

Authors:
Eric Padron

Hematology Am Soc Hematol Educ Program 2015 ;2015:349-54

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2015.1.349DOI Listing
October 2016

Integrating mutation variant allele frequency into clinical practice in myeloid malignancies.

Hematol Oncol Stem Cell Ther 2016 Sep 11;9(3):89-95. Epub 2016 May 11.

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hemonc.2016.04.003DOI Listing
September 2016

Clinical management of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.

Cancer Biol Med 2016 Sep;13(3):360-372

Malignant Hematology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.20892/j.issn.2095-3941.2016.0043DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069836PMC
September 2016

Immunosuppressive Therapy: Exploring an Underutilized Treatment Option for Myelodysplastic Syndrome.

Clin Lymphoma Myeloma Leuk 2016 08;16 Suppl:S44-8

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2016.02.017DOI Listing
August 2016

Eltrombopag Use in Patients With Chronic Myelomonocytic Leukemia (CMML): A Cautionary Tale.

Clin Lymphoma Myeloma Leuk 2016 08;16 Suppl:S64-6

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2016.02.009DOI Listing
August 2016

Autoimmune diseases and myelodysplastic syndromes.

Am J Hematol 2016 May 4;91(5):E280-3. Epub 2016 Apr 4.

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24333DOI Listing
May 2016

Clinical prognostic factors and outcomes of essential thrombocythemia when transformed to myelodysplastic syndromes and acute myeloid leukemia.

Leuk Res 2016 Mar 2;42:52-8. Epub 2016 Feb 2.

Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2016.01.015DOI Listing
March 2016

Myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: an update on risk stratification, molecular genetics, and therapeutic approaches including allogeneic hematopoietic stem cell transplantation.

Am Soc Clin Oncol Educ Book 2015 :e398-412

From the Section of Hematology/Oncology, and the Comprehensive Cancer Center, The University of Chicago, Chicago, IL; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy; Moffitt Cancer Center, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2015.35.e398DOI Listing
February 2016

Detection of a PDGFRB fusion in refractory CMML without eosinophilia: A case for broad spectrum tumor profiling.

Leuk Res Rep 2015 24;4(2):70-1. Epub 2015 Sep 24.

Department of Hematologic Malignancies and Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lrr.2015.07.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672079PMC
December 2015

Lenalidomide Treatment for Lower Risk Nondeletion 5q Myelodysplastic Syndromes Patients Yields Higher Response Rates When Used Before Azacitidine.

Clin Lymphoma Myeloma Leuk 2015 Nov 2;15(11):705-10. Epub 2015 Sep 2.

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2015.08.083DOI Listing
November 2015

Transformation of the Clinical Management of CMML Patients Through In-Depth Molecular Characterization.

Clin Lymphoma Myeloma Leuk 2015 Jun;15 Suppl:S50-5

Malignant Hematology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2015.03.005DOI Listing
June 2015

Validation of the Lower-Risk MD Anderson Prognostic Scoring System for Patients With Myelodysplastic Syndrome.

Clin Lymphoma Myeloma Leuk 2015 Jun;15 Suppl:S60-3

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2015.03.011DOI Listing
June 2015

A close association of autoimmune-mediated processes and autoimmune disorders with chronic myelomonocytic leukemia: observation from a single institution.

Acta Haematol 2015 20;133(2):249-56. Epub 2014 Nov 20.

Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Fla., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000365877DOI Listing
April 2015

Current state of prognostication and risk stratification in myelodysplastic syndromes.

Curr Opin Hematol 2015 Mar;22(2):146-54

aSection of Hematology, Department of Internal Medicine, Yale University, New Haven, Connecticut bDepartment of Malignant Hematology, H Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0000000000000110DOI Listing
March 2015

Cutting the cord from myelodysplastic syndromes: chronic myelomonocytic leukemia-specific biology and management strategies.

Curr Opin Hematol 2015 Mar;22(2):163-70

aH. Lee Moffitt Cancer Center, Tampa, Florida bDana-Farber Cancer Institute, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0000000000000112DOI Listing
March 2015

The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromes.

Leuk Res 2015 Jan 6;39(1):6-17. Epub 2014 Nov 6.

Department of Hematologic Malignancies, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2014.10.006DOI Listing
January 2015

Phase II clinical study of erlotinib for treatment of myelodysplastic syndromes.

Am J Hematol 2014 Aug 16;89(8):809-12. Epub 2014 May 16.

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23749DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561860PMC
August 2014

The clinical management of chronic myelomonocytic leukemia.

Clin Adv Hematol Oncol 2014 Mar;12(3):172-8

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

View Article

Download full-text PDF

Source
March 2014

Deletion 5q MDS: molecular and therapeutic implications.

Best Pract Res Clin Haematol 2013 Dec 16;26(4):365-75. Epub 2013 Oct 16.

H Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2013.10.013DOI Listing
December 2013

Multikinase inhibitors for treating high-risk myelodysplastic syndromes: can this be brought into clinical practice?

Expert Rev Hematol 2013 Oct 2;6(5):485-7. Epub 2013 Oct 2.

University of Maryland Greenebaum Cancer Center, Baltimore, 22 S. Greene Street, S9D04B, Baltimore, MD 21201, USA +1 410 328 2567 +1 410 328 6896

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.2013.827884DOI Listing
October 2013

Prognostic factors and risk models in myelodysplastic syndromes.

Clin Lymphoma Myeloma Leuk 2013 Sep;13 Suppl 2:S295-9

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2013.05.022DOI Listing
September 2013

Importance of genetics in the clinical management of chronic myelomonocytic leukemia.

J Clin Oncol 2013 Jul 20;31(19):2374-6. Epub 2013 May 20.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.48.9120DOI Listing
July 2013

Advances in the management of myelofibrosis.

Cancer Control 2012 Oct;19(4 Suppl):4-15

Department of Malignant Hematology at the H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida 33617, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/107327481201904s04DOI Listing
October 2012

Validation of the MD Anderson Prognostic Risk Model for patients with myelodysplastic syndrome.

Cancer 2012 May 28;118(10):2659-64. Epub 2011 Sep 28.

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.26567DOI Listing
May 2012

The 5q- syndrome: biology and treatment.

Curr Treat Options Oncol 2011 Dec;12(4):354-68

H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-011-0165-1DOI Listing
December 2011

Biology and treatment of the 5q- syndrome.

Expert Rev Hematol 2011 Feb;4(1):61-9

Hematologic Malignancy Division, H Lee Moffitt Cancer Center, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/ehm.11.2DOI Listing
February 2011

Structure of adeno-associated virus serotype 8, a gene therapy vector.

J Virol 2007 Nov 29;81(22):12260-71. Epub 2007 Aug 29.

Department of Biochemistry and Molecular Biology, Center for Structural Biology, McKnight Brain Institute, University of Florida, Gainesville, FL 32610, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.01304-07DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2168965PMC
November 2007

Structurally mapping the diverse phenotype of adeno-associated virus serotype 4.

J Virol 2006 Dec 13;80(23):11556-70. Epub 2006 Sep 13.

Department of Biochemistry and Molecular Biology, Center for Structural Biology, The McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL 32610, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.01536-06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1642620PMC
December 2006

Production, purification, crystallization and preliminary X-ray analysis of adeno-associated virus serotype 8.

Acta Crystallogr Sect F Struct Biol Cryst Commun 2005 Jun 1;61(Pt 6):558-61. Epub 2005 Jun 1.

Department of Biochemistry and Molecular Biology, Center for Structural Biology, McKnight Brain Institute, University of Florida, Gainesville, FL 32610, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1107/S1744309105014132DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1952340PMC
June 2005

Structure of adeno-associated virus type 4.

J Virol 2005 Apr;79(8):5047-58

Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, FL 32610, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.79.8.5047-5058.2005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1069529PMC
April 2005

Isolation and characterization of subgenomic DNAs encapsidated in "single" T = 1 isometric particles of Maize streak virus.

Virology 2004 May;323(1):164-71

Department of Biochemistry and Molecular Biology, College of Medicine, McKnight Brain Institute, University of Florida, Gainesville, FL 32610-0245, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S004268220400140
Publisher Site
http://dx.doi.org/10.1016/j.virol.2004.02.014DOI Listing
May 2004